Search Results - "Hashii, Yoshiko"

Refine Results
  1. 1

    Incidence of second primary cancers among survivors of childhood cancer: A population‐based study, Osaka, Japan, 1975–2015 by Odani, Satomi, Nakata, Kayo, Inoue, Masami, Kato, Mizuki, Saito, Mari Kajiwara, Morishima, Toshitaka, Hashii, Yoshiko, Hara, Junich, Kawa, Keisei, Miyashiro, Isao

    Published in Cancer science (01-03-2023)
    “…Second primary cancer (SPC) is one of the most life‐threatening late effects of childhood cancers. We investigated the incidence and survival outcomes of SPC…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Preclinical Development of a WT1 Oral Cancer Vaccine Using a Bacterial Vector to Treat Castration-Resistant Prostate Cancer by Kitagawa, Koichi, Gonoi, Reina, Tatsumi, Maho, Kadowaki, Masahide, Katayama, Takane, Hashii, Yoshiko, Fujisawa, Masato, Shirakawa, Toshiro

    Published in Molecular cancer therapeutics (01-05-2019)
    “…Previously, we constructed a recombinant displaying a partial mouse Wilms' tumor 1 (WT1) protein ( 420) as an oral cancer vaccine using a bacterial vector and…”
    Get full text
    Journal Article
  6. 6

    Enhanced antitumor activity of a novel, oral, helper epitope-containing WT1 protein vaccine in a model of murine leukemia by Minagawa, Hikaru, Hashii, Yoshiko, Nakajima, Hiroko, Fujiki, Fumihiro, Morimoto, Soyoko, Nakata, Jun, Shirakawa, Toshiro, Katayama, Takane, Tsuboi, Akihiro, Ozono, Keiichi

    Published in BMC cancer (20-02-2023)
    “…A Wilms' tumor 1 (WT1) oral vaccine, Bifidobacterium longum (B. longum) 420, in which the bacterium is used as a vector for WT1 protein, triggers immune…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Checkpoint inhibitor-induced gastritis followed by delayed severe hepatitis in a patient with lung metastases of head and neck squamous cell carcinoma: a case report by Otsuka, Tomoyuki, Hashii, Yoshiko, Murayama, Sei, Ishizuka, Yasunobu, Kojitani, Yoshiki, Nishio, Minako, Kudo, Toshihiro

    Published in Frontiers in oncology (12-05-2023)
    “…Pembrolizumab, an anti-programmed death-1 (PD-1) receptor monoclonal antibody, is an effective first-line therapy for metastatic head and neck squamous cell…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 protocol in Japan by Yanagisawa, Ryu, Nakazawa, Yozo, Matsuda, Kazuyuki, Yasumi, Takahiro, Kanegane, Hirokazu, Ohga, Shouichi, Morimoto, Akira, Hashii, Yoshiko, Imaizumi, Masue, Okamoto, Yasuhiro, Saito, Akiko M., Horibe, Keizo, Ishii, Eiichi

    Published in International journal of hematology (01-02-2019)
    “…Recent advances in intensive chemo- and immunotherapy have contributed to the outcome of hemophagocytic lymphohistiocytosis (HLH); however, the prognosis of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20